ID   GLIS3_HUMAN             Reviewed;         775 AA.
AC   Q8NEA6; B1AL19; Q1PHK5;
DT   13-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   08-FEB-2011, sequence version 5.
DT   28-JUN-2023, entry version 165.
DE   RecName: Full=Zinc finger protein GLIS3;
DE   AltName: Full=GLI-similar 3;
DE   AltName: Full=Zinc finger protein 515;
GN   Name=GLIS3; Synonyms=ZNF515;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS PRO-269
RP   AND GLN-301.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND INVOLVEMENT IN NDH.
RX   PubMed=16715098; DOI=10.1038/ng1802;
RA   Senee V., Chelala C., Duchatelet S., Feng D., Blanc H., Cossec J.-C.,
RA   Charon C., Nicolino M., Boileau P., Cavener D.R., Bougneres P., Taha D.,
RA   Julier C.;
RT   "Mutations in GLIS3 are responsible for a rare syndrome with neonatal
RT   diabetes mellitus and congenital hypothyroidism.";
RL   Nat. Genet. 38:682-687(2006).
RN   [4]
RP   TISSUE SPECIFICITY.
RX   PubMed=14500813; DOI=10.1093/nar/gkg776;
RA   Kim Y.-S., Nakanishi G., Lewandoski M., Jetten A.M.;
RT   "GLIS3, a novel member of the GLIS subfamily of Kruppel-like zinc finger
RT   proteins with repressor and activation functions.";
RL   Nucleic Acids Res. 31:5513-5525(2003).
RN   [5]
RP   INVOLVEMENT IN NDH.
RX   PubMed=21139041; DOI=10.1530/eje-10-0893;
RA   Dimitri P., Warner J.T., Minton J.A., Patch A.M., Ellard S.,
RA   Hattersley A.T., Barr S., Hawkes D., Wales J.K., Gregory J.W.;
RT   "Novel GLIS3 mutations demonstrate an extended multisystem phenotype.";
RL   Eur. J. Endocrinol. 164:437-443(2011).
CC   -!- FUNCTION: Acts as both a repressor and activator of transcription.
CC       Binds to the consensus sequence 5'-GACCACCCAC-3' (By similarity).
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q8NEA6; Q9UMX1: SUFU; NbExp=3; IntAct=EBI-744456, EBI-740595;
CC       Q8NEA6; P46937: YAP1; NbExp=2; IntAct=EBI-744456, EBI-1044059;
CC       Q8NEA6-2; O95817: BAG3; NbExp=3; IntAct=EBI-12232117, EBI-747185;
CC       Q8NEA6-2; Q99828: CIB1; NbExp=5; IntAct=EBI-12232117, EBI-372594;
CC       Q8NEA6-2; Q3LI64: KRTAP6-1; NbExp=3; IntAct=EBI-12232117, EBI-12111050;
CC       Q8NEA6-2; Q9HC98-4: NEK6; NbExp=3; IntAct=EBI-12232117, EBI-11750983;
CC       Q8NEA6-2; Q13077: TRAF1; NbExp=3; IntAct=EBI-12232117, EBI-359224;
CC       Q8NEA6-2; Q96RU7: TRIB3; NbExp=3; IntAct=EBI-12232117, EBI-492476;
CC       Q8NEA6-2; Q15654: TRIP6; NbExp=3; IntAct=EBI-12232117, EBI-742327;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8NEA6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NEA6-2; Sequence=VSP_038299;
CC   -!- TISSUE SPECIFICITY: In the adult, expressed at high levels in the
CC       kidney and at lower levels in the brain, skeletal muscle, pancreas,
CC       liver, lung, thymus and ovary. {ECO:0000269|PubMed:14500813}.
CC   -!- DISEASE: Diabetes mellitus, neonatal, with congenital hypothyroidism
CC       (NDH) [MIM:610199]: A syndrome of neonatal diabetes syndrome associated
CC       with congenital hypothyroidism, congenital glaucoma, hepatic fibrosis
CC       and polycystic kidneys. {ECO:0000269|PubMed:16715098,
CC       ECO:0000269|PubMed:21139041}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the GLI C2H2-type zinc-finger protein family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL158012; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL133283; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL137071; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC033899; AAH33899.2; -; mRNA.
DR   EMBL; DQ438877; ABE66434.1; -; mRNA.
DR   CCDS; CCDS43784.1; -. [Q8NEA6-2]
DR   CCDS; CCDS6451.1; -. [Q8NEA6-1]
DR   RefSeq; NP_001035878.1; NM_001042413.1. [Q8NEA6-2]
DR   RefSeq; NP_689842.3; NM_152629.3. [Q8NEA6-1]
DR   RefSeq; XP_005251443.1; XM_005251386.4. [Q8NEA6-1]
DR   RefSeq; XP_011516065.1; XM_011517763.2. [Q8NEA6-2]
DR   RefSeq; XP_011516066.1; XM_011517764.2. [Q8NEA6-2]
DR   RefSeq; XP_011516068.1; XM_011517766.2. [Q8NEA6-1]
DR   RefSeq; XP_016869850.1; XM_017014361.1. [Q8NEA6-1]
DR   AlphaFoldDB; Q8NEA6; -.
DR   SMR; Q8NEA6; -.
DR   BioGRID; 127988; 31.
DR   CORUM; Q8NEA6; -.
DR   IntAct; Q8NEA6; 13.
DR   MINT; Q8NEA6; -.
DR   STRING; 9606.ENSP00000371398; -.
DR   iPTMnet; Q8NEA6; -.
DR   PhosphoSitePlus; Q8NEA6; -.
DR   BioMuta; GLIS3; -.
DR   DMDM; 322510143; -.
DR   jPOST; Q8NEA6; -.
DR   MassIVE; Q8NEA6; -.
DR   MaxQB; Q8NEA6; -.
DR   PaxDb; Q8NEA6; -.
DR   PeptideAtlas; Q8NEA6; -.
DR   ProteomicsDB; 73140; -. [Q8NEA6-1]
DR   ProteomicsDB; 73141; -. [Q8NEA6-2]
DR   Antibodypedia; 23977; 122 antibodies from 21 providers.
DR   DNASU; 169792; -.
DR   Ensembl; ENST00000324333.14; ENSP00000325494.10; ENSG00000107249.24. [Q8NEA6-1]
DR   Ensembl; ENST00000381971.8; ENSP00000371398.3; ENSG00000107249.24. [Q8NEA6-2]
DR   Ensembl; ENST00000682749.1; ENSP00000507306.1; ENSG00000107249.24. [Q8NEA6-1]
DR   GeneID; 169792; -.
DR   KEGG; hsa:169792; -.
DR   MANE-Select; ENST00000381971.8; ENSP00000371398.3; NM_001042413.2; NP_001035878.1. [Q8NEA6-2]
DR   UCSC; uc003zhw.2; human. [Q8NEA6-1]
DR   AGR; HGNC:28510; -.
DR   CTD; 169792; -.
DR   DisGeNET; 169792; -.
DR   GeneCards; GLIS3; -.
DR   HGNC; HGNC:28510; GLIS3.
DR   HPA; ENSG00000107249; Tissue enhanced (brain, choroid plexus).
DR   MalaCards; GLIS3; -.
DR   MIM; 610192; gene.
DR   MIM; 610199; phenotype.
DR   neXtProt; NX_Q8NEA6; -.
DR   OpenTargets; ENSG00000107249; -.
DR   Orphanet; 79118; Neonatal diabetes-congenital hypothyroidism-congenital glaucoma-hepatic fibrosis-polycystic kidneys syndrome.
DR   PharmGKB; PA134878768; -.
DR   VEuPathDB; HostDB:ENSG00000107249; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   GeneTree; ENSGT00940000156896; -.
DR   HOGENOM; CLU_014147_1_0_1; -.
DR   InParanoid; Q8NEA6; -.
DR   OMA; SECGRMQ; -.
DR   OrthoDB; 2900023at2759; -.
DR   PhylomeDB; Q8NEA6; -.
DR   TreeFam; TF350216; -.
DR   PathwayCommons; Q8NEA6; -.
DR   SignaLink; Q8NEA6; -.
DR   SIGNOR; Q8NEA6; -.
DR   BioGRID-ORCS; 169792; 17 hits in 1180 CRISPR screens.
DR   ChiTaRS; GLIS3; human.
DR   GenomeRNAi; 169792; -.
DR   Pharos; Q8NEA6; Tbio.
DR   PRO; PR:Q8NEA6; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; Q8NEA6; protein.
DR   Bgee; ENSG00000107249; Expressed in buccal mucosa cell and 152 other tissues.
DR   ExpressionAtlas; Q8NEA6; baseline and differential.
DR   Genevisible; Q8NEA6; HS.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISS:BHF-UCL.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; ISS:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISS:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISS:UniProtKB.
DR   Gene3D; 3.30.160.60; Classic Zinc Finger; 5.
DR   InterPro; IPR043359; GLI-like.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR45718; TRANSCRIPTIONAL ACTIVATOR CUBITUS INTERRUPTUS; 1.
DR   PANTHER; PTHR45718:SF1; ZINC FINGER PROTEIN GLIS3; 1.
DR   Pfam; PF00096; zf-C2H2; 2.
DR   SMART; SM00355; ZnF_C2H2; 5.
DR   SUPFAM; SSF57667; beta-beta-alpha zinc fingers; 3.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 4.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 5.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Congenital hypothyroidism;
KW   Diabetes mellitus; DNA-binding; Metal-binding; Nucleus; Reference proteome;
KW   Repeat; Repressor; Transcription; Transcription regulation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..775
FT                   /note="Zinc finger protein GLIS3"
FT                   /id="PRO_0000047211"
FT   ZN_FING         345..370
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         379..406
FT                   /note="C2H2-type 2; atypical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         412..436
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         442..466
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         472..496
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          121..147
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          282..314
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          485..512
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          529..665
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           491..507
FT                   /note="Bipartite nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        121..136
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        286..309
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        584..601
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        630..665
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         1
FT                   /note="M -> MNGRSCSMSLHRTSGTPQGPRMVSGHHIPAIRAHSGTPGPSPCGSTS
FT                   SPTMASLANNLHLKMPSGGGMAPQNNVAESRIHLPALSPRRQMLTNGKPRFQVTQAGGM
FT                   SGSHTLKPKQQEFGSPFPPNPGKGALGFGPQCKSIGKGSCNNLVVTSSPM (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_038299"
FT   VARIANT         269
FT                   /note="S -> P (in dbSNP:rs806052)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_047148"
FT   VARIANT         301
FT                   /note="P -> Q (in dbSNP:rs6415788)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_031062"
FT   VARIANT         578
FT                   /note="P -> L (in dbSNP:rs10973986)"
FT                   /id="VAR_047149"
FT   CONFLICT        347
FT                   /note="C -> Y (in Ref. 2; AAH33899)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   775 AA;  83636 MW;  1C8519AFCDF6C813 CRC64;
     MMVQRLGLIS PPASQVSTAC NQISPSLQRA MNAANLNIPP SDTRSLISRE SLASTTLSLT
     ESQSASSMKQ EWSQGYRALP SLSNHGSQNG LDLGDLLSLP PGTSMSSNSV SNSLPSYLFG
     TESSHSPYPS PRHSSTRSHS ARSKKRALSL SPLSDGIGID FNTIIRTSPT SLVAYINGSR
     ASPANLSPQP EVYGHFLGVR GSCIPQPRPV PGSQKGVLVA PGGLALPAYG EDGALEHERM
     QQLEHGGLQP GLVNHMVVQH GLPGPDSQSA GLFKTERLEE FPGSTVDLPP APPLPPLPPP
     PGPPPPYHAH AHLHHPELGP HAQQLALPQA TLDDDGEMDG IGGKHCCRWI DCSALYDQQE
     ELVRHIEKVH IDQRKGEDFT CFWAGCPRRY KPFNARYKLL IHMRVHSGEK PNKCTFEGCE
     KAFSRLENLK IHLRSHTGEK PYLCQHPGCQ KAFSNSSDRA KHQRTHLDTK PYACQIPGCT
     KRYTDPSSLR KHVKAHSSKE QQARKKLRSS TELHPDLLTD CLTVQSLQPA TSPRDAAAEG
     TVGRSPGPGP DLYSAPIFSS NYSSRSGTAA GAVPPPHPVS HPSPGHNVQG SPHNPSSQLP
     PLTAVDAGAE RFAPSAPSPH HISPRRVPAP SSILQRTQPP YTQQPSGSHL KSYQPETNSS
     FQPNGIHVHG FYGQLQKFCP PHYPDSQRIV PPVSSCSVVP SFEDCLVPTS MGQASFDVFH
     RAFSTHSGIT VYDLPSSSSS LFGESLRSGA EDATFLQIST VDRCPSQLSS VYTEG
//
